Ranbaxy Q3 net up 48% at Rs 207 cr

New Delhi, Oct 18 (UNI) Pharma major Ranbaxy Laboratories Ltd (RLL) today said it has registered 48 per cent increase in net profit at Rs 207.40 crore for the quarter ended September 30 as compared to Rs 140.13 crore in the same period a year ago.

The company's consolidated revenues during the quarter grew 15 per cent to 406 million dollars compared to 353.04 million dollar in the said period.

The company said the Board of Directors also approved an in-principle de-merger of the Drug Discovery Research set-up into a separate company and declared an interim dividend of Rs 2.50 per share.

UNI